Molecular Partners Ag (MOLN) Common Equity: 2020-2025
Historic Common Equity for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to $119,418.
- Molecular Partners Ag's Common Equity fell 25.45% to $119,418 in Q3 2025 from the same period last year, while for Sep 2025 it was $119,418, marking a year-over-year decrease of 25.45%. This contributed to the annual value of $160,998 for FY2024, which is 99.92% down from last year.
- According to the latest figures from Q3 2025, Molecular Partners Ag's Common Equity is $119,418, which was down 7.31% from $128,836 recorded in Q2 2025.
- Molecular Partners Ag's 5-year Common Equity high stood at $198.9 million for Q4 2023, and its period low was $119,418 during Q3 2025.
- In the last 3 years, Molecular Partners Ag's Common Equity had a median value of $172,027 in 2024 and averaged $18.2 million.
- Its Common Equity has fluctuated over the past 5 years, first spiked by 81,366.32% in 2023, then tumbled by 99.92% in 2024.
- Quarterly analysis of 5 years shows Molecular Partners Ag's Common Equity stood at $116.4 million in 2021, then tumbled by 99.79% to $244,107 in 2022, then skyrocketed by 81,366.32% to $198.9 million in 2023, then tumbled by 99.92% to $161,681 in 2024, then dropped by 25.45% to $119,418 in 2025.
- Its last three reported values are $119,418 in Q3 2025, $128,836 for Q2 2025, and $142,583 during Q1 2025.